Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2017 2
2019 4
2020 2
2021 2
2022 1
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Bevacizumab in advanced lung cancer: state of the art.
Assoun S, Brosseau S, Steinmetz C, Gounant V, Zalcman G. Assoun S, et al. Future Oncol. 2017 Dec;13(28):2515-2535. doi: 10.2217/fon-2017-0302. Epub 2017 Aug 16. Future Oncol. 2017. PMID: 28812378 Review.
RET-Rearranged Lung Adenocarcinoma with Paraneoplastic Meige Syndrome.
Abbar B, Henry C, Theou-Anton N, Brosseau S, Nguenang M, Pluvy J, Assoun S, Zalcman G, Gounant V. Abbar B, et al. Among authors: assoun s. J Thorac Oncol. 2019 Nov;14(11):e250-e251. doi: 10.1016/j.jtho.2019.06.008. J Thorac Oncol. 2019. PMID: 31668323 Free article. No abstract available.
Efficacy of Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine in Patients With Thoracic Cancer: A Prospective Study Supporting a Third Dose in Patients With Minimal Serologic Response After Two Vaccine Doses.
Gounant V, Ferré VM, Soussi G, Charpentier C, Flament H, Fidouh N, Collin G, Namour C, Assoun S, Bizot A, Brouk Z, Vicaut E, Teixeira L, Descamps D, Zalcman G. Gounant V, et al. Among authors: assoun s. J Thorac Oncol. 2022 Feb;17(2):239-251. doi: 10.1016/j.jtho.2021.10.015. Epub 2021 Nov 16. J Thorac Oncol. 2022. PMID: 34798306 Free PMC article.
Definitions, outcomes, and management of hyperprogression in patients with non-small-cell lung cancer treated with immune checkpoint inhibitors.
Abbar B, De Castelbajac V, Gougis P, Assoun S, Pluvy J, Tesmoingt C, Théou-Anton N, Cazes A, Namour C, Khalil A, Gounant V, Besse B, Zalcman G, Brosseau S. Abbar B, et al. Among authors: assoun s. Lung Cancer. 2021 Feb;152:109-118. doi: 10.1016/j.lungcan.2020.12.026. Epub 2020 Dec 28. Lung Cancer. 2021. PMID: 33385736
11 results